Primary study · included by 1 review
Salivary evaluation in radioactive I<sup>131</sup> treated patients with thyroid carcinoma
Daniel 2018 · Daniel Filipe Ivan, Lima Luiza Dutra, Grando Liliane Janete, et al. · Acta Odontologica Scandinavica · 2017
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Xerostomia (pooled prevalence) Radioiodine (I131) therapy · within 2 months after RIT | Prevalence 0.60 [0.28, 0.85] | 3 studies · 1502 participants | GRADE not reported |
1 including review in total.